Nekrasova, T. A., Strongin, L. G., Belikina, D. V., Malysheva, E. S., & Nekrasov, A. A. (2023). Results of a 12-month follow-up of patients with type 2 diabetes mellitus after hospitalization with COVID-19: Gliclazide MR use in the hospital and metabolic status at the posthospital stage. Endocrinology Research Centre.
Chicago Style (17th ed.) CitationNekrasova, T. A., L. G. Strongin, D. V. Belikina, E. S. Malysheva, and A. A. Nekrasov. Results of a 12-month Follow-up of Patients with Type 2 Diabetes Mellitus After Hospitalization with COVID-19: Gliclazide MR Use in the Hospital and Metabolic Status at the Posthospital Stage. Endocrinology Research Centre, 2023.
MLA (9th ed.) CitationNekrasova, T. A., et al. Results of a 12-month Follow-up of Patients with Type 2 Diabetes Mellitus After Hospitalization with COVID-19: Gliclazide MR Use in the Hospital and Metabolic Status at the Posthospital Stage. Endocrinology Research Centre, 2023.